Get started
AMPHASTAR PHARMACEUTICALS INC AMPHASTAR PHARMACEUTICALS INC AMPHASTAR PHARMACEUTICALS INC

AMPHASTAR PHARMACEUTICALS INC

No trades
See on Supercharts
Overview
Financials News Ideas Technicals Forecast

29A chart

Upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats

Market capitalization
‪1.96 B‬EUR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
14.85
Basic EPS (TTM)
2.97EUR
Net income (FY)
‪124.62 M‬EUR
Revenue (FY)
‪583.83 M‬EUR
Shares float
‪35.38 M‬
Beta (1Y)
1.01

About Amphastar Pharmaceuticals, Inc.

Sector
Health Technology
CEO
Yong Feng Zhang
Headquarters
Rancho Cucamonga
Website
amphastar.com
Employees (FY)
‪1.76 K‬
Founded
1996
Amphastar Pharmaceuticals, Inc. engages in developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, and insulin active pharmaceutical ingredient. It operates through Finished Pharmaceutical Products and Active Pharmaceutical Ingredients Products segments. The Finished Pharmaceutical Products segment manufactures, markets, and distributes Primatene Mist, enoxaparin, naloxone, phytonadione, lidocaine, and other critical and non-critical care drugs. The Active Pharmaceutical Ingredients Products segment offers RHI API and porcine insulin API for external customers and internal product development. The company was founded by Zi-Ping Luo and Yong Feng Zhang on February 29, 1996 and is headquartered in Rancho Cucamonga, CA.

Financials

Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

Ideas

See all ideas 

News

Keep reading

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating

An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 29A is 39.76 EUR — it has increased by 0.28% in the past 24 hours. Watch AMPHASTAR PHARMACEUTICALS INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange AMPHASTAR PHARMACEUTICALS INC stocks are traded under the ticker 29A.
29A stock has risen by 1.82% compared to the previous week, the month change is a 9.17% rise, over the last year AMPHASTAR PHARMACEUTICALS INC has showed a 3.50% decrease.
We've gathered analysts' opinions on AMPHASTAR PHARMACEUTICALS INC future price: according to them, 29A price has a max estimate of 65.25 EUR and a min estimate of 45.95 EUR. Watch 29A chart and read a more detailed AMPHASTAR PHARMACEUTICALS INC stock forecast: see what analysts think of AMPHASTAR PHARMACEUTICALS INC and suggest that you do with its stocks.
29A reached its all-time high on Aug 9, 2023 with the price of 61.50 EUR, and its all-time low was 26.20 EUR and was reached on Jan 10, 2023. View more price dynamics on 29A chart.
See other stocks reaching their highest and lowest prices.
29A stock is 0.89% volatile and has beta coefficient of 1.01. Track AMPHASTAR PHARMACEUTICALS INC stock price on the chart and check out the list of the most volatile stocks — is AMPHASTAR PHARMACEUTICALS INC there?
Today AMPHASTAR PHARMACEUTICALS INC has the market capitalization of ‪1.96 B‬, it has increased by 0.67% over the last week.
Yes, you can track AMPHASTAR PHARMACEUTICALS INC financials in yearly and quarterly reports right on TradingView.
AMPHASTAR PHARMACEUTICALS INC is going to release the next earnings report on Aug 5, 2024. Keep track of upcoming events with our Earnings Calendar.
29A earnings for the last quarter are 0.96 EUR per share, whereas the estimation was 0.72 EUR resulting in a 34.49% surprise. The estimated earnings for the next quarter are 0.73 EUR per share. See more details about AMPHASTAR PHARMACEUTICALS INC earnings.
AMPHASTAR PHARMACEUTICALS INC revenue for the last quarter amounts to ‪159.25 M‬ EUR despite the estimated figure of ‪161.86 M‬ EUR. In the next quarter revenue is expected to reach ‪159.69 M‬ EUR.
29A net income for the last quarter is ‪40.02 M‬ EUR, while the quarter before that showed ‪32.77 M‬ EUR of net income which accounts for 22.12% change. Track more AMPHASTAR PHARMACEUTICALS INC financial stats to get the full picture.
No, 29A doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of May 20, 2024, the company has ‪1.76 K‬ employees. See our rating of the largest employees — is AMPHASTAR PHARMACEUTICALS INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. AMPHASTAR PHARMACEUTICALS INC EBITDA is ‪243.38 M‬ EUR, and current EBITDA margin is 37.47%. See more stats in AMPHASTAR PHARMACEUTICALS INC financial statements.
Like other stocks, 29A shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade AMPHASTAR PHARMACEUTICALS INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So AMPHASTAR PHARMACEUTICALS INC technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating AMPHASTAR PHARMACEUTICALS INC stock shows the sell signal. See more of AMPHASTAR PHARMACEUTICALS INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.